Indian Journal of Nuclear Medicine
Home | About IJNM | Search | Current Issue | Past Issues | Instructions | Ahead of Print | Online submissionLogin 
Indian Journal of Nuclear Medicine
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 183 Print this page  Email this page Small font size Default font size Increase font size

 Table of Contents     
Year : 2019  |  Volume : 34  |  Issue : 2  |  Page : 86-87  

Phase analysis: A new armamentarium in nuclear cardiology

Department of Nuclear Medicine and PET/CT, Centre for Advanced Research in Imaging, Neuroscience and Genomics, Sir Ganga Ram Hospital, New Delhi, India

Date of Web Publication8-Apr-2019

Correspondence Address:
Dr. Dharmender Malik
Department of Nuclear Medicine and PET/CT, Centre for Advanced Research in Imaging, Neuroscience and Genomics, Sir Ganga Ram Hospital, New Delhi
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijnm.IJNM_36_19

Rights and Permissions

How to cite this article:
Malik D. Phase analysis: A new armamentarium in nuclear cardiology. Indian J Nucl Med 2019;34:86-7

How to cite this URL:
Malik D. Phase analysis: A new armamentarium in nuclear cardiology. Indian J Nucl Med [serial online] 2019 [cited 2022 Jan 22];34:86-7. Available from:

Phase analysis tool has evolved significantly since its inception in 2005 by Chen et al.[1] It has added another dimension to cardiac assessment using radionuclide techniques for the detection of left ventricular mechanical dyssynchrony (LVMD). LVMD refers to asynchronous mechanical contraction and/or relaxation between different segments of the left ventricle. It is important to acknowledge that mechanical dyssynchrony does not equal electrical dyssynchrony which is defined by an asynchronous electrical activation of the left ventricular (LV) leading to a prolonged QRS duration (>120 ms) on the electrocardiogram.[2] Prolonged QRS duration is one of the significant constituents of traditional criteria for the selection of cardiac resynchronization therapy (CRT) candidates; other components include LV ejection fraction ≤35% and New York Heart Association class II-IV despite optimal medical therapy. Based on the current traditional criteria, ~20%–30% of patients fail to show an improvement in clinical symptoms and cardiac function after CRT, suggesting the need for a more efficient selection of CRT candidates to improve patient outcomes.[3] Phase analysis might come to the rescue of these patients as the assessment of LVMD has shown to aid in selecting the CRT candidates. LMVD has been studied using several imaging modalities including echocardiography (M-mode, color tissue Doppler, strain imaging, and three-dimensional echo), cardiac magnetic resonance imaging, and cardiac radionuclide techniques including myocardial perfusion imaging (MPI) single-photon emission tomography (SPECT) and positron emission tomography and gated blood pool imaging.[1],[4] Dyssynchrony analysis using radionuclide techniques has several advantages over other modalities including the use of automated technology, ease of standardization to ensure reliability and reproducibility, and lack of limitations such as requiring proper acoustic window which has been adequately highlighted in the present study published in the current issue by Singhal et al.[5]

The author has compared the utility of equilibrium radionuclide angiography (ERNA) with the speckle tracking echocardiography (STE) in the diagnosis of LVMD in a subset of 55 patients with dilated cardiomyopathy. STE could not be performed in thirteen patients (24%), which was attributed to poor acoustic window owing to the thick chest wall (obesity), rib crowding artifacts, and obstructive airway disease. Offline speckle tracking on the images of these patients was visually found to be inconsistent, with poor reproducibility, highlighting significant limitations of STE despite its wider availability and applicability. Furthermore, the author could detect the LVMD in greater number of patients (31 vs. 27 respectively) on ERNA as compared to the STE. These findings highlight the utility of ERNA in the detection of LVMD in greater number of patients and subsequent better management which can be easily missed on the STE due to various reasons. Among the study population, the author also compared the relationship of electrical versus mechanical dyssynchrony between wide QRS and narrow QRS group using both ERNA and STE techniques, and no significant association of QRS duration was noted with LVMD. Furthermore, the presence of LBBB does not alter LVMD status suggestive of its independent existence from electrical dyssynchrony, as all patients with wide QRS do not show LVMD. The present study shows that 24% of the patients did not show LVMD despite having QRS width >120 ms. This percentage is very similar to the proportion of nonresponders in the various CRT trials, giving impetus to the hypothesis that the presence of LVMD may be a necessary factor behind the response to CRT.

Studies in patients with ischemic and nonischemic cardiomyopathy have shown that LVMD is associated with a higher risk of mortality and portends a poor prognosis. LV mechanical dyssynchrony even in the absence of perfusion or function abnormalities has shown to predict adverse cardiovascular outcomes in women, in patients with diabetes mellitus and patients with end-stage renal disease.[4],[6],[7],[8] Being noninvasive, operator independent, highly reproducible, and relatively easy to perform, phase analysis seems to be one of the most promising techniques to quantify left ventricle dyssynchrony in comparison to the conventionally available techniques. Its ability to apply on retrospective data provides further advantage, and it can be expressed in units of degree/angle (°) or time, i.e., milliseconds depending upon cardiologist preference. Limited availability of gamma camera and nonstandardization of the dyssynchrony parameters restricts its use as the investigation of choice for diagnoses of LVMD.

Besides these drawbacks, we should consider incorporating dyssynchrony analysis in the routine interpretation of cardiac radionuclide techniques (SPECT-MPI and ERNA) along with other parameters whenever possible. However, this would require a standardization of the dyssynchrony parameters and a seamless incorporation of analysis algorithm in the programs used for interpretation in routine clinical practice. Although phase analysis is known for a long time, this modality is grossly underutilized for the evaluation of cardiac dyssynchrony. Heart failure patients, who despite optimal medical therapy continue to be symptomatic, should be selected for CRT if significant cardiac mechanical dyssynchrony is detected on phase analysis, for a better result.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

   References Top

Chen J, Garcia EV, Folks RD, Cooke CD, Faber TL, Tauxe EL, et al. Onset of left ventricular mechanical contraction as determined by phase analysis of ECG-gated myocardial perfusion SPECT imaging: Development of a diagnostic tool for assessment of cardiac mechanical dyssynchrony. J Nucl Cardiol 2005;12:687-95.  Back to cited text no. 1
Yu CM, Yang H, Lau CP, Wang Q, Wang S, Lam L, et al. Regional left ventricle mechanical asynchrony in patients with heart disease and normal QRS duration: Implication for biventricular pacing therapy. Pacing Clin Electrophysiol 2003;26:562-70.  Back to cited text no. 2
Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices): Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008;117:e350-408.  Back to cited text no. 3
Mukherjee A, Patel CD, Naik N, Sharma G, Roy A. Quantitative assessment of cardiac mechanical dyssynchrony and prediction of response to cardiac resynchronization therapy in patients with non-ischaemic dilated cardiomyopathy using equilibrium radionuclide angiography. Europace 2016;18:851-7.  Back to cited text no. 4
Singhal A, Khangembam BC, Seth S, Patel C. Equilibrium radionuclide angiography in evaluation of left ventricular mechanical dyssynchrony in patients with dilated cardiomyopathy: Comparison with electrocardiographic parameters and speckle tracking echocardiography. Indian J Nucl Med 2019;34:88-95.  Back to cited text no. 5
  [Full text]  
Sharma RK, Volpe G, Rosen BD, Ambale-Venkatesh B, Donekal S, Fernandes V, et al. Prognostic implications of left ventricular dyssynchrony for major adverse cardiovascular events in asymptomatic women and men: The multi-ethnic study of atherosclerosis. J Am Heart Assoc 2014;3. pii: e000975.  Back to cited text no. 6
Malik D, Mittal BR, Sood A, Parmar M, Kaur K, Bahl A, et al. Prognostic value of left ventricular mechanical dyssynchrony indices in long-standing type II diabetes mellitus with normal perfusion and left ventricular systolic functions on SPECT-MPI. J Nucl Cardiol 2018. Doi: 10.1007/s12350-018-1436-z. [Epub ahead of print].  Back to cited text no. 7
Aggarwal H, AlJaroudi WA, Mehta S, Mannon R, Heo J, Iskandrian AE, et al. The prognostic value of left ventricular mechanical dyssynchrony using gated myocardial perfusion imaging in patients with end-stage renal disease. J Nucl Cardiol 2014;21:739-46.  Back to cited text no. 8


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this article

 Article Access Statistics
    PDF Downloaded174    
    Comments [Add]    

Recommend this journal